Positive Patient Stories™

Paratek Pharmaceuticals News

Webcast ImageWebcast
Fourth Quarter and Fiscal Year 2018 Earnings Call  (Replay)
02/27/19 at 4:30 p.m. ET
Fourth Quarter and Fiscal Year 2018 Earnings Call
Wednesday, February 27, 2019 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
8th Annual SVB Leerink Global Healthcare Conference (Replay)
02/28/19 at 1:00 p.m. ET
8th Annual SVB Leerink Global Healthcare Conference
Thursday, February 28, 2019 1:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Paratek Pharmaceuticals Presentation at the Cowen and Company 39th Annual Health Care Conference (Replay)
03/13/19 at 10:00 a.m. ET
Paratek Pharmaceuticals Presentation at the Cowen and Company 39th Annual Health Care Conference
Wednesday, March 13, 2019 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2019 | 2018 | 2017 | 2016 | 2015
DateTitle  
03/18/19Paratek Pharmaceuticals Announces Management Change 
03/01/19Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) 
03/01/19Paratek Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference 
02/27/19Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results 
02/14/19Paratek Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference 
02/13/19Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results on February 27, 2019 
02/06/19New England Journal of Medicine Publishes Results from Pivotal Phase 3 Studies of Paratek’s NUZYRA™ (Omadacycline) For Pneumonia and Skin Infections 
02/05/19Paratek Pharmaceuticals Launches NUZYRA™ (Omadacycline) in the United States 
02/01/19Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) 
01/02/19Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) 

Talk with the Paratek Team

Send us an inquiry by submitting a form directly on the site or give us a call.